For example, IDH-Mutant tumors exhibiting CDKN2A mutations were associated with aggressive behavior and a mean survival time of 1.6 years, comparable to GBM, whereas IDH-Mutant tumors without this mutation have a mean survival time of 12.6 years [24]. Here, CDKN2A is linked to glioblastoma.